Feeds › Capitol Hires
Capitol Hires
Lobbyists whose filings say they once worked in a member of Congress' office, on a committee or in the executive branch, with the public company that hired them.
About this data
- What it is
- Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
- Who files it
- The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
- How current
- New filings are posted every day. We read each one the day after it is posted.
- Terms
- Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
- Worth knowing
- Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.
All of this comes from lobbying disclosure filings that the Senate and the House publish.
Information, not investment advice (disclaimer). Where this data comes from.
Latest Capitol Hires
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|---|
| GSK GSK plc | Edward Prettyman | Thomas R. Carper Member office · Democrat-DE | Legislative Correspondent and Constituent Services Representative | Sims Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| GSK GSK plc | Michaela Sims | Ben Nelson Member office · Democrat-NE | Legislative Counsel | Sims Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| GSK GSK plc | Michaela Sims | Bob Kerrey (Senate) Member office · Senate | Legislative Director and Counsel | Sims Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| GSK GSK plc | Monica Popp | John Cornyn Member office · Republican-TX | Chief of Staff/Deputy Chief of Staff | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| GSK GSK plc | Monica Popp | Commerce Committee Committee | Professional Staff Member, U.S. House of Representatives-Energy | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| GSK GSK plc | Monica Popp | Jim DeMint Member office · Republican-SC | Legislative Assistant | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| GSK GSK plc | Hazen Marshall | Mitch McConnell Member office · Republican-KY | Policy Director | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| GSK GSK plc | Hazen Marshall | Senate Budget Committee Committee | Staff Director | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| GSK GSK plc | Hazen Marshall | Don Nickles (Senate) Member office · Senate | Legislative Assistant | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| GSK GSK plc | Daniel Todd | Senate Finance Committee Committee | Senior Health Counsel | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Daniel Todd | Office of Admin. Executive branch | Special Assistant, Ct. - Medicare & Medicaid | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Paul Edattel | Commerce Committee Committee | Professional Staff Member for the Majority at the House Energy | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Paul Edattel | John Shadegg (House) Member office · House | Legislative Assistant & Legislative Director | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Nicholas Uehlecke | Dept. of Health and Human Services Executive branch | Senior Advisor | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Nicholas Uehlecke | House Ways and Means Subcommittee Committee | Professional Staff/Sr. Legislative Assistant | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Katherine Cotton | Brett Guthrie Member office · Republican-KY | Staff Assistant, Legislative Correspondent, Legislative Assistant | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Eric Bergren | Brett Guthrie Member office · Republican-KY | Chief of Staff | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Eric Bergren | Ron Lewis (House) Member office · House | Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Eric Bergren | Bill Baker (House) Member office · House | Intern | Todd Strategy Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Robert Wood | HHS Executive branch | Chief of Staff to Secretary | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Robert Wood | Scott Klug (House) Member office · House | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Brent del Monte | Bliley (House) Member office · House | Leg. Dir | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Brent del Monte | Commerce Committee Committee | Sen. Counsel House Energy | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Robb Walton | Senate HELP Committee | Senior Health Policy Advisor and Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Robb Walton | Cassidy (House) Member office · House | ; Advisor | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Robb Walton | Enzi (Senate) Member office · Senate | ; Research Asst., Staff Asst., Intern on , Ranking Member | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Robb Walton | Nunes (House) Member office · House | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | John Stone | Oversight Subcommittee Committee | Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | John Stone | House E&C Cmte Committee | Senior Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | John Stone | Health Subcommittee Committee | Senior Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | John Stone | House Energy and Commerce Committee | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Daniel Farmer | Debbie Wasserman Schultz Member office · Democrat-FL | Intern, Staff Asst, Leg. Corr./Leg. Asst | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Daniel Farmer | Zack Space Member office | Leg. Asst., Sr. Leg. Asst., Leg. Dir | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Joel Bailey | Panetta (House) Member office · House | COS | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Joel Bailey | Ashford (House) Member office · House | LD | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Joel Bailey | Matheson (House) Member office · House | LD | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Joel Bailey | Matsui (House) Member office · House | Sr. LA | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Joel Bailey | Baron Hill (House) Member office · House | LA, Sr. LA | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Joel Bailey | Rahall (House) Member office · House | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Remy Mason | Senate HELP Committee Committee | Senior FDA Policy Advisor to Ranking Member Patty Murray | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Remy Mason | Elizabeth Warren Member office · Democrat-MA | Senior Health Policy Advisor | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Remy Mason | Allyson Y. Schwartz Member office · Democrat-PA | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Raghav Aggarwal | Senate Finance Committee Committee | Senior Health Advisor | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Raghav Aggarwal | Detailee (Senate) Member office · Senate | Senior Health Advisor | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Raghav Aggarwal | Ron Wyden Member office · Democrat-OR | Not stated | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Raghav Aggarwal | CMS Executive branch | Social Science Research Analyst | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Raghav Aggarwal | Feinstein (Senate) Member office · Senate | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Raghav Aggarwal | US Dept. of Interior Executive branch | Secretarys Fellow | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| GSK GSK plc | Chris Kelly | Blackburn (Senate) Member office · Senate | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 7 filings |
| GSK GSK plc | Alanna Temme | Jon Porter (House) Member office · House | Legislative Director | LMH Strategic Solutions | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 8 filings |
The newest 50 of 90 matching. Narrow them with the filters above.
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 5:08 PM EST.